Clinical Care Pathway for the Risk Stratification and Management of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease

The authors aim to update the clinical care pathway for managing metabolic dysfunction-associated steatotic liver disease (MASLD) in light of recent advancements in understanding the condition and new treatment options. They provide guidance on screening, diagnosing, and treating MASLD, incorporating an implementation framework to ensure the pathway is applicable across various healthcare settings. This update reflects the latest evidence and aims to improve patient care for those affected by MASLD.